Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Atricure Inc (ATRC)

Atricure Inc (ATRC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
33.40 -0.35 (-1.04%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 33.40 unch (unch) 16:01 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
32.63
Day High
33.57
Open 33.53
Previous Close 33.75 33.75
Volume 426,100 426,100
Avg Vol 485,585 485,585
Stochastic %K 77.29% 77.29%
Weighted Alpha +35.25 +35.25
5-Day Change +1.39 (+4.34%) +1.39 (+4.34%)
52-Week Range 18.94 - 43.11 18.94 - 43.11
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,549,657
  • Shares Outstanding, K 49,494
  • Annual Sales, $ 465,310 K
  • Annual Income, $ -44,700 K
  • EBIT $ -40 M
  • EBITDA $ -21 M
  • 60-Month Beta 1.65
  • Price/Sales 3.55
  • Price/Cash Flow N/A
  • Price/Book 3.57

Options Overview Details

View History
  • Implied Volatility 76.01% ( -9.62%)
  • Historical Volatility 49.98%
  • IV Percentile 67%
  • IV Rank 69.25%
  • IV High 106.87% on 07/26/24
  • IV Low 6.50% on 05/10/24
  • Put/Call Vol Ratio 0.25
  • Today's Volume 5
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 202
  • Open Int (30-Day) 429

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.25
  • Number of Estimates 4
  • High Estimate -0.21
  • Low Estimate -0.27
  • Prior Year -0.25
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.48 +13.30%
on 04/07/25
Period Open: 34.85
35.63 -6.26%
on 03/26/25
-1.45 (-4.16%)
since 03/25/25
3-Month
29.48 +13.30%
on 04/07/25
Period Open: 40.58
43.11 -22.52%
on 01/29/25
-7.18 (-17.69%)
since 01/24/25
52-Week
18.94 +76.35%
on 06/18/24
Period Open: 22.61
43.11 -22.52%
on 01/29/25
+10.79 (+47.72%)
since 04/25/24

Most Recent Stories

More News
AtriCure: Q4 Earnings Snapshot

AtriCure: Q4 Earnings Snapshot

ATRC : 33.40 (-1.04%)
AtriCure: Q3 Earnings Snapshot

AtriCure: Q3 Earnings Snapshot

ATRC : 33.40 (-1.04%)
AtriCure: Q2 Earnings Snapshot

AtriCure: Q2 Earnings Snapshot

ATRC : 33.40 (-1.04%)
AtriCure: Q1 Earnings Snapshot

AtriCure: Q1 Earnings Snapshot

ATRC : 33.40 (-1.04%)
AtriCure: Q4 Earnings Snapshot

AtriCure: Q4 Earnings Snapshot

ATRC : 33.40 (-1.04%)
AtriCure: Q3 Earnings Snapshot

AtriCure: Q3 Earnings Snapshot

ATRC : 33.40 (-1.04%)
AtriCure: Q2 Earnings Snapshot

AtriCure: Q2 Earnings Snapshot

ATRC : 33.40 (-1.04%)
AtriCure: Q1 Earnings Snapshot

AtriCure: Q1 Earnings Snapshot

ATRC : 33.40 (-1.04%)
AtriCure Reports First Quarter 2023 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 33.40 (-1.04%)
AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today...

ATRC : 33.40 (-1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as...

See More

Key Turning Points

3rd Resistance Point 34.71
2nd Resistance Point 34.14
1st Resistance Point 33.77
Last Price 33.40
1st Support Level 32.83
2nd Support Level 32.26
3rd Support Level 31.89

See More

52-Week High 43.11
Fibonacci 61.8% 33.88
Last Price 33.40
Fibonacci 50% 31.03
Fibonacci 38.2% 28.17
52-Week Low 18.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective